Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of clinical outcomes in patients with neuropsychiatric systemic lupus erythematosus.
Ichinose K, Arima K, Umeda M, Fukui S, Nishino A, Nakashima Y, Suzuki T, Horai Y, Koga T, Kawashiri SY, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Nakamura H, Sato S, Origuchi T, Kawakami A. Ichinose K, et al. Among authors: nakashima y. Cytokine. 2016 Mar;79:31-7. doi: 10.1016/j.cyto.2015.12.010. Epub 2015 Dec 30. Cytokine. 2016. PMID: 26745468
Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.
Ichinose K, Arima K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, Nakajima H, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Motomura M, Kawakami A. Ichinose K, et al. Among authors: nakashima y. Clin Immunol. 2015 Apr;157(2):114-20. doi: 10.1016/j.clim.2015.01.010. Epub 2015 Feb 3. Clin Immunol. 2015. PMID: 25656641 Free article.
Eosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy: Is Simultaneous Systemic Lupus Erythematosus Associated With Clinical Manifestations?: A Case Report and Review of the Literature.
Fukui S, Iwamoto N, Tsuji S, Umeda M, Nishino A, Nakashima Y, Suzuki T, Horai Y, Koga T, Kawashiri SY, Ichinose K, Hirai Y, Tamai M, Nakamura H, Origuchi T, Kinoshita N, Kawakami A. Fukui S, et al. Among authors: nakashima y. Medicine (Baltimore). 2015 Nov;94(45):e1943. doi: 10.1097/MD.0000000000001943. Medicine (Baltimore). 2015. PMID: 26559264 Free PMC article. Review.
Soluble α-klotho is a potential biomarker associated with neuropsychiatric systemic lupus erythematosus.
Ushigusa T, Ichinose K, Sato S, Michitsuji T, Shimizu T, Umeda M, Fukui S, Nishino A, Nakashima Y, Koga T, Kawashiri SY, Iwamoto N, Hirai Y, Tamai M, Nakamura H, Origuchi T, Kawakami A. Ushigusa T, et al. Among authors: nakashima y. Clin Immunol. 2016 Apr;165:29-34. doi: 10.1016/j.clim.2016.03.001. Epub 2016 Mar 4. Clin Immunol. 2016. PMID: 26960950
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.
Kita J, Tamai M, Arima K, Nakashima Y, Suzuki T, Kawashiri SY, Okada A, Koga T, Yamasaki S, Nakamura H, Origuchi T, Aramaki T, Nakashima M, Fujikawa K, Tsukada T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Kita J, et al. Among authors: nakashima m, nakashima y. Mod Rheumatol. 2012 Apr;22(2):195-201. doi: 10.1007/s10165-011-0511-y. Epub 2011 Sep 6. Mod Rheumatol. 2012. PMID: 21898075 Clinical Trial.
Soluble urokinase plasminogen activator receptor as a useful biomarker to predict the response to adalimumab in patients with rheumatoid arthritis in a Japanese population.
Koga T, Okada A, Kawashiri S, Kita J, Suzuki T, Nakashima Y, Tamai M, Satoh K, Origuchi T, Iwamoto N, Yamasaki S, Nakamura H, Migita K, Ida H, Ueki Y, Eguchi K, Kawakami A. Koga T, et al. Among authors: nakashima y. Clin Exp Rheumatol. 2011 Sep-Oct;29(5):811-5. Epub 2011 Oct 31. Clin Exp Rheumatol. 2011. PMID: 22011479 Clinical Trial.
The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.
Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri SY, Iwamoto N, Suzuki T, Nakashima Y, Tamai M, Arima K, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Ishimatsu Y, Mukae H, Kuwana M, Kohno S, Eguchi K, Aoyagi K, Kawakami A. Koga T, et al. Among authors: nakashima y. Rheumatology (Oxford). 2012 Jul;51(7):1278-84. doi: 10.1093/rheumatology/ker518. Epub 2012 Feb 29. Rheumatology (Oxford). 2012. PMID: 22378718 Free article.
Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach.
Kita J, Tamai M, Arima K, Kawashiri SY, Horai Y, Iwamoto N, Okada A, Koga T, Nakashima Y, Suzuki T, Yamasaki S, Nakamura H, Origuchi T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Kita J, et al. Among authors: nakashima y. Mod Rheumatol. 2013 Mar;23(2):254-9. doi: 10.1007/s10165-012-0646-5. Epub 2012 Jun 6. Mod Rheumatol. 2013. PMID: 22669596
Confirmation of effectiveness of tocilizumab by ultrasonography and magnetic resonance imaging in biologic agent-naïve early-stage rheumatoid arthritis patients.
Kawashiri SY, Suzuki T, Nakashima Y, Horai Y, Okada A, Iwamoto N, Ichinose K, Tamai M, Arima K, Nakamura H, Origuchi T, Uetani M, Aoyagi K, Kawakami A. Kawashiri SY, et al. Among authors: nakashima y. Mod Rheumatol. 2015;25(6):948-53. doi: 10.3109/14397595.2013.844394. Epub 2013 Nov 13. Mod Rheumatol. 2015. PMID: 24252054
Presence of ultrasound subclinical synovitis and increment of serum vascular endothelial growth factor in a patient with rheumatoid arthritis achieved in sustained clinical remission by treatment with adalimumab and methotrexate.
Kawashiri SY, Arima K, Suzuki T, Nakashima Y, Horai Y, Okada A, Tamai M, Nakamura H, Kawakami A. Kawashiri SY, et al. Among authors: nakashima y. Mod Rheumatol. 2014 Jul;24(4):681-4. doi: 10.3109/14397595.2013.874736. Epub 2014 Feb 18. Mod Rheumatol. 2014. PMID: 24533548
2,466 results